{"transactions":[{"id":1954773,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":115595,"kind":"person","name":"Gelder Mark S. MD","position":1,"cik":"0001564390","reported_name":"Gelder Mark S. MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2023-03-14T22:46:02.000Z","date":"2023-03-13","kind":"grant","acquired":true,"shares":20667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is convertible into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary"}],"balance_after":20667,"derivative":{"underlying":"Common Stock","underlying_shares":20667},"source":{"system":"sec-edgar","filing":"0001415889-23-004865","document":"form4-03142023_100352.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923004865/form4-03142023_100352.xml","form_type":"4"}},{"id":1954772,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":115595,"kind":"person","name":"Gelder Mark S. MD","position":1,"cik":"0001564390","reported_name":"Gelder Mark S. MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to purchase)","published_at":"2023-03-14T22:46:02.000Z","date":"2023-03-13","kind":"grant","acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years."}],"balance_after":62000,"derivative":{"exercise_price":0.73,"expiration_date":"2033-03-13","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001415889-23-004865","document":"form4-03142023_100352.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923004865/form4-03142023_100352.xml","form_type":"4"}},{"id":2026809,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":115595,"kind":"person","name":"Gelder Mark S. MD","position":1,"cik":"0001564390","reported_name":"Gelder Mark S. MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2023-02-08T22:58:04.000Z","date":"2023-02-07","kind":"exercise","acquired":false,"shares":5833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 7, 2022 the reporting person was granted 17,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 7, 2022 the reporting person was granted 17,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary."}],"balance_after":11667,"derivative":{"underlying":"Common Stock","underlying_shares":5833},"source":{"system":"sec-edgar","filing":"0001415889-23-002168","document":"form4-02082023_100255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923002168/form4-02082023_100255.xml","form_type":"4"}},{"id":2026808,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":115595,"kind":"person","name":"Gelder Mark S. MD","position":1,"cik":"0001564390","reported_name":"Gelder Mark S. MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-02-08T22:58:04.000Z","date":"2023-02-07","kind":"tax_withholding","acquired":false,"shares":1242,"price":1.36,"value":1689.12,"ownership":{"direct":true},"balance_after":10487,"source":{"system":"sec-edgar","filing":"0001415889-23-002168","document":"form4-02082023_100255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923002168/form4-02082023_100255.xml","form_type":"4"}},{"id":2026807,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":115595,"kind":"person","name":"Gelder Mark S. MD","position":1,"cik":"0001564390","reported_name":"Gelder Mark S. MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-02-08T22:58:04.000Z","date":"2023-02-07","kind":"exercise","acquired":true,"shares":5833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":11729,"source":{"system":"sec-edgar","filing":"0001415889-23-002168","document":"form4-02082023_100255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923002168/form4-02082023_100255.xml","form_type":"4"}},{"id":2194714,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":115595,"kind":"person","name":"Gelder Mark S. MD","position":1,"cik":"0001564390","reported_name":"Gelder Mark S. MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2022-08-04T20:34:22.000Z","date":"2022-08-02","kind":"exercise","acquired":false,"shares":4650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 2, 2021 the reporting person was granted 13,950 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 2, 2021 the reporting person was granted 13,950 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."}],"balance_after":9300,"derivative":{"underlying":"Common Stock","underlying_shares":4650},"source":{"system":"sec-edgar","filing":"0001415889-22-008260","document":"form4-08042022_010823.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588922008260/form4-08042022_010823.xml","form_type":"4"}},{"id":2194713,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":115595,"kind":"person","name":"Gelder Mark S. MD","position":1,"cik":"0001564390","reported_name":"Gelder Mark S. MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2022-08-04T20:34:22.000Z","date":"2022-08-03","kind":"tax_withholding","acquired":false,"shares":1135,"price":1.32,"value":1498.2,"ownership":{"direct":true},"balance_after":5896,"source":{"system":"sec-edgar","filing":"0001415889-22-008260","document":"form4-08042022_010823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588922008260/form4-08042022_010823.xml","form_type":"4"}},{"id":2194712,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":115595,"kind":"person","name":"Gelder Mark S. MD","position":1,"cik":"0001564390","reported_name":"Gelder Mark S. MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2022-08-04T20:34:22.000Z","date":"2022-08-02","kind":"exercise","acquired":true,"shares":4650,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":7031,"source":{"system":"sec-edgar","filing":"0001415889-22-008260","document":"form4-08042022_010823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588922008260/form4-08042022_010823.xml","form_type":"4"}},{"id":2406725,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":115595,"kind":"person","name":"Gelder Mark S. MD","position":1,"cik":"0001564390","reported_name":"Gelder Mark S. MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-09T21:52:49.000Z","date":"2022-02-07","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is convertible into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."}],"balance_after":17500,"derivative":{"underlying":"Common stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001179110-22-000964","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911022000964/edgar.xml","form_type":"4"}},{"id":2406724,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":115595,"kind":"person","name":"Gelder Mark S. MD","position":1,"cik":"0001564390","reported_name":"Gelder Mark S. MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to purchase)","published_at":"2022-02-09T21:52:49.000Z","date":"2022-02-07","kind":"grant","acquired":true,"shares":51750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years."}],"balance_after":51750,"derivative":{"exercise_price":1.82,"expiration_date":"2032-02-07","underlying":"Common stock","underlying_shares":51750},"source":{"system":"sec-edgar","filing":"0001179110-22-000964","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911022000964/edgar.xml","form_type":"4"}},{"id":2556884,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":115595,"kind":"person","name":"Gelder Mark S. MD","position":1,"cik":"0001564390","reported_name":"Gelder Mark S. MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-29T12:25:48.000Z","date":"2021-09-28","kind":"purchase","acquired":true,"shares":2381,"price":4.2,"value":10000.2,"ownership":{"direct":true},"balance_after":2381,"source":{"system":"sec-edgar","filing":"0001179110-21-008981","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911021008981/edgar.xml","form_type":"4"}},{"id":2615475,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":115595,"kind":"person","name":"Gelder Mark S. MD","position":1,"cik":"0001564390","reported_name":"Gelder Mark S. MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2021-08-05T00:02:49.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":13950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is convertible into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary."}],"balance_after":13950,"derivative":{"underlying":"Common stock","underlying_shares":13950},"source":{"system":"sec-edgar","filing":"0001179110-21-007924","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911021007924/edgar.xml","form_type":"4"}},{"id":2615474,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":115595,"kind":"person","name":"Gelder Mark S. MD","position":1,"cik":"0001564390","reported_name":"Gelder Mark S. MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to purchase)","published_at":"2021-08-05T00:02:49.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":41825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years."}],"balance_after":41825,"derivative":{"exercise_price":5.19,"expiration_date":"2031-08-02","underlying":"Common stock","underlying_shares":41825},"source":{"system":"sec-edgar","filing":"0001179110-21-007924","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911021007924/edgar.xml","form_type":"4"}},{"id":2664321,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":115595,"kind":"person","name":"Gelder Mark S. MD","position":1,"cik":"0001564390","reported_name":"Gelder Mark S. MD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to purchase)","published_at":"2021-06-17T23:46:07.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Theses options vest over 4 years, 25% on the first anniversary of the grant and thereafter in 36 equal monthly installments over the next 3 years."}],"balance_after":20000,"derivative":{"exercise_price":7.56,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001179110-21-006842","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911021006842/edgar.xml","form_type":"4"}}]}